Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 818-824

  Bates, A S ^a   Farrell, W E ^a   Bicknell, E J ^a   McNicol, A M ^b   Talbot, A J ^a   Broome, J C ^a   Perrett, C W ^c   Thakker, R V ^d   Clayton, R N ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICROSATELLITE DNA; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 1P; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADENOMA; ADOLESCENT; ADULT; AGED; ALLELES; BIOLOGICAL MARKERS; CHROMOSOME MAPPING; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; PROGNOSIS;

EID: 0031037481     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.818     Document Type: Article

References (20)

1. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. 1993 Association or somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest. 91:2815-2821.
2. Boggild MD, Jenkinson S, Pistorello M, et al. 1994 Molecular mechanisms of pituitary tumor formation; evidence of genetic heterogeneity tumor initiation. J Clin Endocrinol Metab. 78:387-392.
3. Pei L, Melmed S, Scheithauer B, Kovaks K, Benedict WF, Prager D. 1995 Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumours: evidence for a chromosome 13 tumour gene other than RB. Cancer Res. 55:1613-1616.
4. Cryns VL, Alexander JM, Klibanski A, Arnold A. 1993 The retinoblastoma gene in human pituitary tumours. J Clin Endocrinol Metab. 77:644-646.
5. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM. 1994 Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab. 78:922-927.
6. Woloschak M, Roberts JL, Post KD. 1994 Loss of heterozygosity at the retinoblastoma locus inhuman pituitary tumors. Cancer 74:693-696.
7. Buckley N, Bates AS, Broome JC, et al. 1994 53 protein accumulates in Cushing's adenoma and invasive nonfunctional adenomas. J Clin Endocrinol Metab. 79:1513-1516.
8. Levine AJ, Momand J, Finlay CA. 1991 The p53 tumour suppressor gene. Nature. 351:453-456.
9. Fearon ER, Vogelstein B. 1990 A genetic model for colorectal tumorigenesis. J Clin Endocrinol Metab. 61:759-767.
10. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localisation of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumours. Proc Natl Acad Sci USA 87:1968-1972.
11. Hardy J. 1979 Transphenoidal microsurgical treatment of pituitary tumours. In: Linfoot J, ed. Recent advances in the diagnosis and treatment of pituitary tumours. New York: Raven Press; 375-388.
12. Jackson DP, Hayden JD, Quirke P. 1991 Extraction of nucleic acid from fresh and archival material. In: Quirke P, ed. PCR: a practical approach. Oxford: Oxford University Press; 33-40.
13. Dodson MK, Hartmann LC, Cliby WA, et al. 1993 Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res. 53:4456-4460.
14. Deleted in proof.
15. James CD, Carlbom E, Dumanski JP, et al. 1988 Clonal genomic alterations in glial malignancy stages. Cancer Res. 48:5546-5551.
16. Benedict WF, Xu H, Hu S, Takahashi R. 1990 Role of the Retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest. 85:988-993.
17. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992 Effects of an Rb mutation in the mouse. Nature. 359:295-300.
18. Woloschak M, Yu A, Post D. Abundance and state of phosphorylatron of the RB gene product in human pituitary tumours [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 601.
19. Wooster R, Neuhausen SL, Mangion J, et al. 1994 Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265:2088-2090.
20. Hermann MA, Hay ID, Bartelt DH, et al. 1991 Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest. 88: 1596-1604.